TY - JOUR
T1 - A preclinical murine model for the early detection of radiation-induced brain injury using magnetic resonance imaging and behavioral tests for learning and memory
T2 - with applications for the evaluation of possible stem cell imaging agents and therapies
AU - Ngen, Ethel J.
AU - Wang, Lee
AU - Gandhi, Nishant
AU - Kato, Yoshinori
AU - Armour, Michael
AU - Zhu, Wenlian
AU - Wong, John
AU - Gabrielson, Kathleen L.
AU - Artemov, Dmitri
N1 - Funding Information:
The authors would like to thank Mr. Joshua Crawford and Mr. Kevin Rhie for their technical assistance, and Ms. Mary McAllister for editing this manuscript. This research was sponsored by the TEDCO Maryland Stem Cell Research Fund (2010-MSCRFE-0096) and the American Brain Tumor Association (Grant Number: 117704 - ABTA Basic Research in honor of Joel A. Gringas).
Publisher Copyright:
© 2016, Springer Science+Business Media New York.
PY - 2016/6/1
Y1 - 2016/6/1
N2 - Stem cell therapies are being developed for radiotherapy-induced brain injuries (RIBI). Magnetic resonance imaging (MRI) offers advantages for imaging transplanted stem cells. However, most MRI cell-tracking techniques employ superparamagnetic iron oxide particles (SPIOs), which are difficult to distinguish from hemorrhage. In current preclinical RIBI models, hemorrhage occurs concurrently with other injury markers. This makes the evaluation of the recruitment of transplanted SPIO-labeled stem cells to injury sites difficult. Here, we developed a RIBI model, with early injury markers reflective of hippocampal dysfunction, which can be detected noninvasively with MRI and behavioral tests. Lesions were generated by sub-hemispheric irradiation of mouse hippocampi with single X-ray beams of 80 Gy. Lesion formation was monitored with anatomical and contrast-enhanced MRI and changes in memory and learning were assessed with fear-conditioning tests. Early injury markers were detected 2 weeks after irradiation. These included an increase in the permeability of the blood–brain barrier, demonstrated by a 92 ± 20 % contrast enhancement of the irradiated versus the non-irradiated brain hemispheres, within 15 min of the administration of an MRI contrast agent. A change in short-term memory was also detected, as demonstrated by a 40.88 ± 5.03 % decrease in the freezing time measured during the short-term memory context test at this time point, compared to that before irradiation. SPIO-labeled stem cells transplanted contralateral to the lesion migrated toward the lesion at this time point. No hemorrhage was detected up to 10 weeks after irradiation. This model can be used to evaluate SPIO-based stem cell-tracking agents, short-term.
AB - Stem cell therapies are being developed for radiotherapy-induced brain injuries (RIBI). Magnetic resonance imaging (MRI) offers advantages for imaging transplanted stem cells. However, most MRI cell-tracking techniques employ superparamagnetic iron oxide particles (SPIOs), which are difficult to distinguish from hemorrhage. In current preclinical RIBI models, hemorrhage occurs concurrently with other injury markers. This makes the evaluation of the recruitment of transplanted SPIO-labeled stem cells to injury sites difficult. Here, we developed a RIBI model, with early injury markers reflective of hippocampal dysfunction, which can be detected noninvasively with MRI and behavioral tests. Lesions were generated by sub-hemispheric irradiation of mouse hippocampi with single X-ray beams of 80 Gy. Lesion formation was monitored with anatomical and contrast-enhanced MRI and changes in memory and learning were assessed with fear-conditioning tests. Early injury markers were detected 2 weeks after irradiation. These included an increase in the permeability of the blood–brain barrier, demonstrated by a 92 ± 20 % contrast enhancement of the irradiated versus the non-irradiated brain hemispheres, within 15 min of the administration of an MRI contrast agent. A change in short-term memory was also detected, as demonstrated by a 40.88 ± 5.03 % decrease in the freezing time measured during the short-term memory context test at this time point, compared to that before irradiation. SPIO-labeled stem cells transplanted contralateral to the lesion migrated toward the lesion at this time point. No hemorrhage was detected up to 10 weeks after irradiation. This model can be used to evaluate SPIO-based stem cell-tracking agents, short-term.
KW - Magnetic resonance imaging
KW - Radiation-induced brain injury
KW - Radiation-induced brain injury markers
KW - Stem cell therapies
KW - Stem cell tracking
UR - http://www.scopus.com/inward/record.url?scp=84961669843&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84961669843&partnerID=8YFLogxK
U2 - 10.1007/s11060-016-2111-3
DO - 10.1007/s11060-016-2111-3
M3 - Article
C2 - 27021492
AN - SCOPUS:84961669843
SN - 0167-594X
VL - 128
SP - 225
EP - 233
JO - Journal of neuro-oncology
JF - Journal of neuro-oncology
IS - 2
ER -